One of the worst kept secrets at this year's meeting of the European Society of Cardiology (ESC) was confirmed when Dublin-based Medtronic plc confirmed positive outcomes for renal denervation in the treatment of moderate hypertension from the Spyral HTN-Off Med study during a Hot Line session.